Detalhe da pesquisa
1.
Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
World J Urol
; 42(1): 260, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664275
2.
Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
World J Urol
; 41(10): 2699-2705, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626183
3.
The added value of PSMA PET/MR radiomics for prostate cancer staging.
Eur J Nucl Med Mol Imaging
; 49(2): 527-538, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255130
4.
Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study.
J Urol
; 205(6): 1663-1670, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535796
5.
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project).
World J Urol
; 38(1): 151-158, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30937569
6.
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
Front Oncol
; 13: 1113246, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064092
7.
[Aftercare and adjuvant therapy for advanced renal cell carcinoma]. / Nachsorge und adjuvante Therapie des fortgeschrittenen Nierenzellkarzinoms.
Urologe A
; 61(5): 495-499, 2022 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-35377013
8.
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer.
Asian J Urol
; 9(1): 69-74, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35198399
9.
Prospectively Accelerated T2-Weighted Imaging of the Prostate by Combining Compressed SENSE and Deep Learning in Patients with Histologically Proven Prostate Cancer.
Cancers (Basel)
; 14(23)2022 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497223
10.
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy.
EJNMMI Res
; 11(1): 76, 2021 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417907
11.
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC).
Eur Urol Oncol
; 4(2): 256-263, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33384274
12.
Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database.
Cent European J Urol
; 73(3): 273-279, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33133653
13.
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma.
Eur Urol Oncol
; 3(4): 523-529, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414697
14.
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group.
Eur Urol Focus
; 6(5): 982-990, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799289
15.
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263].
Eur Urol Oncol
; 4(3): 517, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33947640